RC
ACET icon

Rangeley Capital’s Adicet Bio ACET Stock Holding History

Rangeley Capital’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$381K Buy
56,000
+30,999
+124% +$232K 0.37% 59
2025
Q4 		$211K Buy
25,001
+20,313
+433% +$225K 0.17% 88
2025
Q3 		$60.8K Buy
+4,688
New +$55.2K 0.05% 116

Other funds holding ACET

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Rangeley Capital's ACET Position: Q1 2026 in Review

Rangeley Capital increased its Adicet Bio (ACET) stake by 124% in Q1 2026, buying an estimated $232K and bringing the position to 56,000 shares worth $381K. The position accounts for 0.37% of the portfolio, ranked #59.

Rangeley Capital first reported a position in ACET in Q3 2025 and has held it in 3 quarters since. 49 funds tracked by Wall St. Rank hold ACET as of Q1 2026.

  • Rangeley Capital held 56,000 shares of Adicet Bio worth $381K as of Q1 2026.
  • Rangeley Capital bought 30,999 Adicet Bio shares in Q1 2026, an estimated $232K.
  • Adicet Bio made up 0.37% of Rangeley Capital's portfolio in Q1 2026, its #59 holding.
  • Rangeley Capital first reported a position in Adicet Bio in Q3 2025 and has held it in 3 quarters since.
  • 49 funds tracked by Wall St. Rank held Adicet Bio as of Q1 2026.

Based on Rangeley Capital's 13F filing for Q1 2026, filed 15 May 2026.